Podcast appearances and mentions of steven edelman

About 1/3 of the adults with type 2 diabetes don't know they have it, according the National Institutes of Health and more than 25% of all newly diagnosed type 2 patients have complications starting. In this episode, learn what typical complications can be, tests that your MD can order to detect complications, how to keep complications from progressing and 5 tips to manage your type 2 diabetes. Interested in more information? Let's chat about how I can help you! Schedule a FREE breakthrough call with me: https://schedule-robinwong.as.me/ Download my 3 Breakfasts to Lower Blood Sugar: https://page.nutritionwithrobinrdn.com/guide Follow me on Instagram and Facebook: Nutrition_with_Robin www.nutritionwithrobinrdn.com Watch for more information on the upcoming free, virtual 2021 Women with T2D Summit June 29, 30, and July 1. Mentioned in this episode Dr. Steven Edelman, Taking Control of Your Diabetes Resources: National Institutes of Health

You guys are in for a treat today. I'm excited to have three giants of the diabetes industry here today to share their insights: Dr. Satish Garg, Dr. Irl Hirsch, and Dr. Steven Edelman. These men need no introduction, but in case you're in the 1% of people who don't know these gentlemen, do a bit of research and come back here when you're done. They are absolutely revolutionary in the world of diabetes devices, investment, and research. So I'm not going to do any fluff today, we're going to dive right into the real talk.  Come be a fly on the wall of this conversation, and join me in learning more about what is impacting the future of diabetes, what we should be excited about, and what we should be looking out for. [00:01 - 06:04] Opening Segment I introduce Satish, Irl, and Dr. Edelman Starting questions Satish talks first about what is currently exciting him in diabetes Devices widely accepted by the patients Companies are improving  Elimination on CGM  Irl follows up with his insights and excitement  Agreeing with Satish  Type 1 and Type 2 penetration The projections of the adolescent generation  Taking a bite out of obesity - game changer  Steven shares what he is currently excited about  Opening up to more screening  [06:05 - 16:01] Golden Insights from the Big 3 Satish talks about the issue of access  Who can afford these things Irl talks about the problem he sees with payers No concern around heart disease A fight for every drug  Satish's thoughts on telehealth What the Covid Pandemic has taught us  Plusses and minuses of telehealth  Irl's thoughts on ‘digital diabetes' ‘It's possible, but you need to show me' Would not invest just yet  Digital apps need to be standardized  There can't be 20 different forms  Everybody has a different approach  [16:05 - 25:00] What is Impacting the Future of Diabetes Satish talks about what he sees happening with patients The example of the creation of the term insulin resistance Why these apps don't work  Nothing replaces communication Nothing works long term that is robust yet The role of social media on diabetes today The issue of misinformation Satish talks about the drugs he likes for each type of diabetes T1 - CGM T2 - GLP Irl talks about what he is looking forward to for the future  T1 - Artificial pancreas  T2 - Zipa Tide Steven's desired outcome for the future T1 - Everyone having access to insulin for both want and need T2 - GLP  [25:01 - 33:32] Closing Segment I get the guys' perspective on a closed-loop system Satish: There are decent insulins that can achieve a decent glucose control Steven: If there is a liquid form, it would work better; insights on rapid-acting Satish: Holistic approach to make an impact  Irl: Too many people driving the ship; dependent on the need for glycemic control The importance of the impact on pregnancy  Focussing on the US Clear message to the industry Start talking to each other, and start thinking about the patients Make the drug too expensive, and only a few will pay for it A lot of money wasted on ‘Me-Too drugs' - lower the price and still profit Thank you and please share this  Final Words  Tweetable Quotes: “If I see someone using a meter, I throw their meter in the trash can and give them a new sensor from the clinic, that's all they're gonna do, and there's not a single patient… who hasn't said, ‘this has changed my life.'” - Dr. Satish Garg “This is a game-changer, so just like insulin, the haves and the have nots - who's going to have access to all these amazing drugs that science has come up with? That to me is the big question.” - Dr. Irl Hirsch   “One reason why these apps don't work is that patients need to have their doctors… nothing replaces communication. Between our broken health care system and the short...

Host Aaron Lohr talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast. This episode is sponsored by an unrestricted, educational grant from Novo Nordisk, Abbott Diabetes Care, and Medtronic.

Host Aaron Lohr talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast. This episode is sponsored by an unrestricted, educational grant from Novo Nordisk, Abbott Diabetes Care, and Medtronic.

Aaron talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast. This episode is sponsored by an unrestricted, educational grant from Novo Nordisk, Abbott Diabetes Care, and Medtronic.

Host: Steven Edelman, MD Guest: Sunder Mudaliar How can we prevent and treat pre-diabetes? Can a pill delay or prevent the onset of disease in high-risk individuals? Host Dr. Steven Edelman talks to Dr. Sunder Mudaliar, clinical professor of medicine in the division of endocrinology and metabolsim at the VA Medical Center and University of California San Diego School of Medicine, about the data on pioglitazone for diabetes prevention and the results of the ACT NOW study.

Host: Steven Edelman, MD Guest: Stephen Ponder, MD, CDE A new study suggests newly trained physicians may not be adequately prepared to treat patients with diabetes. Host Dr. Steven Edelman, talks with Dr. Stephen Ponder, pediatric endocrinologist at Texas A&M, with 27 years of professional experience in the management of children with diabetes, about the implications for the next generation of patients and Dr. Ponder's recommendations for a mentoring system to provide additional training to young physicians.

Host: Steven Edelman, MD Guest: John Walsh, PA, CDE Insulin pump practice studies reveal new approaches in the management of diabetes, including carb-counting, carb boluses, hypoglycemia and transdermal insulin drug delivery. What are actual pump practices that lead to improved control? Join host Dr. Steven Edelman and his guest, John Walsh, PA, and certified diabetes educator at Advanced Metabolic Care and Research in Escondido, California, as they discuss pump practices that lead to improved control.

Host: Steven Edelman, MD Guest: Jane Seley, DNP, MPH The transition from hospital to home for patients with diabetes can be challenging, from glycemic targets, guidelines for initiating insulin therapy, the various types of insulin and oral agents to general nutrition. What are the current recommendations for the transition from hospital to home for patients living with diabetes? Join host Dr. Steven Edelman and his guest, Dr. Jane Jeffrie Seley, diabetes nurse practitioner and certified diabetes educator at New York-Presbyterian Hospital Weill Cornell Medical Center, as they discuss the differences in the current AACE and ADA inpatient and outpatient recommendations.

Host: Steven Edelman, MD Guest: Linda Siminerio, RN, PhD, CDE Insulin therapy can be challenging for both the patient with diabetes and their healthcare provider— from needle phobia to weight gain. How can healthcare providers shorten the learning curve to understanding insulin and its benefits? Join host Dr. Steven Edelman and his guest, Dr. Linda Siminerio, associate professor at the University of Pittsburgh School of Medicine, as they discuss insulin fact and fallacy for patients and providers.

Host: Steven Edelman, MD Guest: David Henderson, MD Antipsychotic medications have dramatically increased in prescriptions, including additional FDA-approved usages for bipolar and depression as well as off-label use. Side effects of these drugs, such as abdominal weight gain, lipid and blood pressure changes, and elevations in fasting glucose, may contribute to metabolic syndrome. What are the impacts of increased use of antipsychotic medications on diabetes? Join host Dr. Steven Edelman and his guest, associate professor of psychiatry at Harvard Medical School, Dr. David Henderson, as they discuss the need for healthcare providers to be proactive: understanding the patient's risk factors, medical history and the risk-benefit ratio in order to treat effectively.

Host: Steven Edelman, MD Guest: Eric Rackow, MD The percentage of healthcare spending on chronic illnesses is increasing exponentially; critically for patients with diabetes. How can healthcare providers help their aging population to manage their diabetes and avoid costly hospital stays through home care management? Join host Dr. Steven Edelman and his guest, professor of medicine at the New York University School of Medicine, Dr. Eric Rackow, as they discuss new approaches for home care management strategies for patients living diabetes.

Host: Steven Edelman, MD Guest: Natalie Strand, MD The management of diabetes is an ongoing challenge for both the healthcare provider and patient in terms of balancing insulin regimens, glucose monitoring, diet and exercise. How does the diabetes educator help to "win the race" for a patient with diabetes? Join host Dr. Steven Edelman and his guest, interventional pain management physician and winner of the Amazing Race, Dr. Natalie Strand, as they discuss the integral role of the diabetes educator in the management of diabetes.

Host: Steven Edelman, MD Guest: Simon Heller, MD In 2004 the American Diabetes Association working group defined the threshold of hypoglycemia as 70 mg/dl. The clinical definition continues to attract controversy with a standard vs. dynamic solution. What are considerations that need to be made in terms of the clinical definition of hypoglycemia? Join host Dr. Steven Edelman and his guest, professor of clinical diabetes at the University of Sheffield, Dr. Simon Heller, as they discuss the challenge with the current threshold of hypoglycemia.

Host: Steven Edelman, MD Guest: Patrick O'Connor, MD A push away from the "one size fits all" approach to diabetes care, including subgroup analyses, patient preference, genetic factors and electronic records, is changing the way healthcare providers are caring for their patients. How do healthcare providers reflect these changes in their practices? Join host Dr. Steven Edelman and his guest, clinician of family medicine and senior investigator for HealthPartners, Dr. Patrick O'Connor, as they discuss a personalized approach to diabetes management.

Host: Steven Edelman, MD Guest: Louis Aronne, MD Treatment regimens for diabetes and obesity are merging. Healthcare professionals are taking a new view to the management of diabetes including rearranging diabetes medication regimens from a glucose control and weight-neutral perspective. What do healthcare professionals need to know to help their patients manage their diabetes? Join host Dr. Steven Edelman and his guest, clinical professor of medicine at Cornell Medical College, Dr. Louis Aronne, as they discuss considerations of drug therapies as weight neutral for treating their patients with type 2 diabetes.

Host: Steven Edelman, MD Guest: Juan Pablo Frías, MD Patients living with type 1 diabetes who are involved in athletics present particular challenges to approaching to their management, medication regimen and nutrition. How can healthcare professionals help their type 1 athletes optimize their performance and manage their diabetes? Join host Dr. Steven Edelman and his guest, director of research at TeamType1, Dr. Juan Frias, as they discuss restrictions, research, monitoring and adjusting insulin therapy for endurance type 1 athletes.

Host: Steven Edelman, MD Guest: Candis Morello, PharmD, CDE Medication adherence is one of the most challenging aspects of managing patients with diabetes. The majority of diabetes patients taking more than one oral agent do not adhere to their prescribed regimens. What is the key to successful adherence to drug regimens in patients living with diabetes? Join host Dr. Steven Edelman and his guest, associate professor of clinical pharmacy at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, Dr. Candis Morello, as they discuss results from a recent study on medication adherence for patients living with diabetes.

Host: Steven Edelman, MD Guest: Azza El-Remessy, PhD, RPh Retinopathy is one of the most common complications for patients living with diabetes but there are few treatment options and no early-stage interventions. How is research helping to pinpoint potential targets for early intervention and a possible oral treatment? Join host Dr. Steven Edelman and his guest, assistant professor and director of clinical and experimental therapeutics at the University of Georgia, Dr. Azza El-Remessy, as they discuss the latest research into the potential of statins to prevent diabetic-related blindness.

Host: Steven Edelman, MD Guest: Jaime Davidson, MD The relationship of insulin regimens to race and ethnicity is a new and growing area of research to better understand and provide clinical care at a personalized level. What are significant differences and approaches to these patients' diabetes management? Join host Dr. Steven Edelman and his guest, professor of internal medicine at the University of Texas Southwestern Medical School, Dr. Jaime Davidson, as they discuss the need for more clinical trials to better understand the differences of race and ethnicity on the efficacy and safety of commonly-used insulin regimens.

Host: Steven Edelman, MD Guest: Tom Baranowski, PhD How are video games showing promise as a behavior change strategy to improve children's diets? Newly-funded video-game programs are specifically designed to lower risk of type 2 diabetes and obesity in children. Join host Dr. Steven Edelman and his guest, professor of pediatrics at Baylor College, Dr. Tom Baranowski as they discuss innovative approaches to behavior change incorporating video games for children. Watch trailers for these games at www.archimage.com.

Host: Steven Edelman, MD Guest: Linda Raynes Mahony, MS, RD, CDE Fifty percent of patients living with diabetes will require some sort of renal replacement therapy. What percent will go on to renal transplantation and what are the recommendations for the management of these patients? Join host Dr. Steven Edelman and his guest, transplant dietitian at the University of California, San Diego, Linda Raynes Mahony, as they discuss medications, nutrition and overall management of renal transplant patients.

Host: Steven Edelman, MD Guest: Matthew Riddle, MD Patients on insulin therapy require personalized approaches to their mealtime intervention. What are the choices for patients who need something more to control glucose after meals? Join host Dr. Steven Edelman and his guest, professor of medicine at the Oregon Health & Science University, Dr. Matthew Riddle as they discuss meal time interventions for the treatment of type 2 diabetes.

Host: Steven Edelman, MD Guest: R. Keith Campbell, BPharm, MBA Changes in both care and treatment of diabetes reflect trends in healthcare that may need revision. How can healthcare professionals benefit from new pharmacotherapies for their patients living with diabetes? Join host Dr. Steven Edelman and his guest, professor of pharmacy, Keith Campbell, as they discuss trends in healthcare that may require revisions for the care of people living with diabetes.

Host: Steven Edelman, MD Guest: Edward Damiano, PhD Guest: Steven Russell, MD, PhD The latest research into the use of glucagon and insulin in a closed-loop system is promising for the management of type 1 diabetes. How will the use of a bihormonal system benefit patients, and what is the path of treatment? Join host Dr. Steven Edelman and his guests, associate professor of biomedical engineering at Boston University, Dr. Edward Damiano, and instructor of medicine at Harvard Medical School, Dr. Steven Russell, as they discuss the challenges of a closed-loop system.

Host: Steven Edelman, MD Guest: Sheri Colberg-Ochs, PhD Today's general exercise regimens for patients living with type 2 diabetes should emphasize a combination of both aerobic exercise and resistance training. What are the new guidelines concerning exercise and what do physicians needs to know when they prescribe exercise for their type 2 patients? Join host Dr. Steven Edelman and his guest, professor of exercise science at Old Dominion University, Dr. Sheri Colberg, as they discuss the American College of Sports Medicine/American Diabetes Association joint statement on exercise for type 2 diabetes.

Host: Steven Edelman, MD Guest: Neal Kaufman, MD, MPH Methods of positive behavioral change for people living with diabetes is vital to the overall management of diabetes. What is the value of behavior change for people living with diabetes and their professional counterparts? Join host Dr. Steven Edelman and his guest, professor of pediatrics and public health at the University of California, Los Angeles, Dr. Neal Kaufman, as they discuss the need for behavior modification in the treatment of type 2 diabetes.

Host: Steven Edelman, MD Guest: Lois Jovanovic, MD, MACE Universal guidelines in screening, diagnosis and early treatment for diabetes and pregnancy are presenting opportunities for the physician and patient to better manage their diabetes and the health of the newborn babies. What are the standards and what is the clinical relevance? Join host Dr. Steven Edelman and his guest, chief scientific officer of the Sansum Diabetes Research Institute, Dr. Lois Jovanovic, as they discuss the need to screen all pregnant women for diabetes.

Host: Steven Edelman, MD Guest: John Buse, MD, PhD The recent American Diabetes Association / European Association for the Study of Diabetes consensus panel produced their treatment algorithm to control glycaemia in type 2 diabetes. How can healthcare professionals treating patients with type 2 diabetes provide additional prandial intervention to reach A1c targets? Join host Dr. Steven Edelman and his guest, professor of medicine at the University of North Carolina School of Medicine, Dr. John Buse, as they discuss the results of the glargine-exenatide combination study and its implications for a preferred treatment algorithm.

Host: Steven Edelman, MD Guest: Jay Skyler, MD Can immune intervention stop the disease process of type 1 diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine, pediatrics and psychology at the University of Miami, Dr. Jay Skyler, as they discuss the diagnosis, screening, testing and current immunotherapy research for the prevention and intervention of type 1 diabetes.

Host: Steven Edelman, MD Guest: Vivian Fonseca, MD, FRCP When should healthcare professionals treating patients with type 2 diabetes consider using insulin or incretin treatment or both? Join host Dr. Steven Edelman and his guest, president-elect of the American Diabetes Association and professor of medicine at Tulane University, Dr. Vivian Fonseca, as they discuss comparative and contrasting effects of both insulin and incretin treatment, the incretin effect and the clinical efficacy and safety of incretin-based therapies.

Host: Steven Edelman, MD Guest: Amy Ozier, PhD, RD The EADS (Eating and Appraisal Due to Emotions and Stress) questionnaire developed by Dr. Amy Ozier, registered dietitian and certified health education specialist, and assistant professor and facilitator of the Certificate of Graduate Study for Eating Disorders and Obesity at Northern Illinois University, helps healthcare professionals determine how psychological and physical factors modulate how much patients with diabetes eat. Does this tool help to bridge the gap when a psychologist is missing from a multi-disciplinary team? Dr. Ozier joins host Dr. Steven Edelman to discuss overeating as a contributing factor in a patient's overall health, the impact of hyperglycemia and treatment that helps modulate behavior.

Host: Steven Edelman, MD Guest: Robert Henry, MD The potential benefits of a new class of medications, sodium-dependent glucose cotransporter-2 therapy (or SGLT-2s), for type 2 diabetes is promising, but where will they fit in the treatment of diabetes and what are the risks? Join host Dr. Steven Edelman and his guest, professor of medicine at the Veterans Affairs Medical Center in San Diego, California, Dr. Robert Henry, as they discuss the mechanism, benefits and potential cardiovascular risks of this new class of medication.

Host: Steven Edelman, MD Guest: Shereen Arent, JD Healthcare reform will have significant implications for both patients living with diabetes and the healthcare professionals treating diabetic patients. How will healthcare reform impact current treatment, access and affordability? Join host Dr. Steven Edelman and his guest, executive vice president of government affairs & advocacy of the American Diabetes Association, Shereen Arent, as they discuss the impact of reform to cost of patient care, current and future prevention programs and the Affordable Care Act.

Host: Steven Edelman, MD Guest: Craig Wargon, DPM Patients with diabetes commonly need treatment for peripheral neuropathy. What are common symptoms and what should a physician be looking for in each patient visit? Join host Dr. Steven Edelman and his guest, practicing physician in the division of podiatric surgery at Kaiser Permanente, Dr. Craig Wargon, as they discuss symptoms, treatment and the need to glycaemic control in patients with diabetes.

Host: Steven Edelman, MD Guest: Ann Albright, PhD, RD The Centers for Disease Control and Prevention is aggressively becoming hands-on in the prevention of type 2 diabetes. A new national diabetes prevention program is under way under the tutelage of previous successful clinical research and trials results. What can healthcare professionals treating patients with diabetes learn and how can they get involved? Join host Dr. Steven Edelman and his guest, the director of the division of diabetes translation at the Centers for Disease Control and Prevention, Dr. Ann Albright, as they discuss the criteria for the National Diabetes Prevention Program.

Host: Steven Edelman, MD Guest: Emmanuel Baetge, PhD Current stem cell therapy research is leading the way into producing functional pancreatic, insulin-producing cells. How will this translate into clinical trials and human therapy for diabetes from a scale, delivery and efficacy position? Join host Dr. Steven Edelman and his guest Dr. Emmanuel Baetge, chief scientific officer of Viacyte, Inc., as they discuss the benefits of stem cell research therapy for diabetes.

Host: Steven Edelman, MD Guest: Robert Cuddihy, MD There have been impressive results with incretin-based therapy for patients with type 2 diabetes: improved A1C, beta-cell preservation and weight loss are some of the benefits. But do healthcare professionals need to temper their enthusiasm for this novel therapy? Join host Dr. Steven Edelman and his guest, medical director of the International Diabetes Center, Park Nicollet Health Services, Dr. Robert Cuddihy, as they discuss whether incretin-based therapy holds promise of a truly disease-modifying therapy.

Host: Steven Edelman, MD Guest: Jennifer B. Green, MD What is known about the relationship between glucose control and cardiovascular disease in diabetes? The recent Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial provides some interesting results on the relationship between type 2 diabetes and silent myocardial infarction. Join host Dr. Steven Edelman and his guest, assistant professor of medicine in the division of endocrinology, metabolism and nutrition at Duke University, Dr. Jennifer Green, as they discuss the role of glycemic control to cardiovascular disease in both sexes.

Host: Steven Edelman, MD Guest: David Kendall, MD The assessment of intensive glycemic control in preventing cardiovascular disease is unclear. Discrepancies in recent clinical trials such as ACCORD, ADVANCE, PROactive and UKPDS 80 may reflect difference in study design and patients, versus glycemic control. How can using the Archimedes model illuminate this quandary? Join host Dr. Steven Edelman and his guest, chief scientific and medical officer of the American Diabetes Association, Dr. David Kendall, as they discuss the effect of glycemic control on macrovascular outcomes in patients with diabetes.

Host: Steven Edelman, MD Guest: Stanley Schwartz, MD Guidelines that avoid the use of oral antidiabetes agents associated with hypoglycemia and weight gain are becoming increasingly popular in treating patients with diabetes. What are we learning about incretin-based therapies in both the intensive care and emergency medicine departments and perioperatively? Join host Dr. Steven Edelman and his guest, associate professor of medicine at the University of Pennsylvania, Dr. Stanley Schwartz, as they discuss the surprising results in both intensive care, emergency medicine and perioperative periods using incretin-based therapies.

Host: Steven Edelman, MD Guest: Ralph A. DeFronzo, MD New information on the state of impaired glucose tolerance indicates that the level of beta cell loss is greater than once considered. New treatment regimens are being considered to combat both the insulin sensitivity and beta cell loss for type 2 diabetes. What do health care professionals need to understand about the critical first steps in both the assessment and treatment of patients with type 2 diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine at the University of Texas Health Science Center, Dr. Ralph DeFronzo, as they discuss the potential of early combination and triple therapy to preserve beta cell function.

Host: Steven Edelman, MD Guest: Fred Toffel, MD Are the current ADA guidelines for inpatient care enough in the management of patients with diabetes? How are areas such as identification, assessment, glycemic control and nutrition therapy integrated? How are we approaching optimal glycemic control for inpatient care? Join host Dr. Steven Edelman and his guest, endocrinologist in Las Vegas, Nevada, Dr. Fred Toffel, as they discuss unique approaches to inpatient care for patients with diabetes.

Host: Steven Edelman, MD Guest: Aaron Kowalski, PhD The Artificial Pancreas Project under the auspices of the Juvenile Diabetes Research Foundation is making strides towards closing the loop with improvements in communication between glucose sensors and external insulin pumps. What progress has been made in closing the loop in the development of the artificial pancreas? Join host Dr. Steven Edelman and his guest, director of glucose control research at JDRF, Dr. Aaron Kowalski, as they discuss current systems and future development of the artificial pancreas.

Host: Steven Edelman, MD Guest: Barbara Rolls, PhD Current studies are reflecting the relationship between dietary energy density and energy intake in the management of the obese and patients with diabetes. How can physicians learn to integrate diet strategies for weight management in their patients with diabetes? Join host Dr. Steven Edelman and his guest, professor of nutritional sciences at Penn State University, Dr. Barbara Rolls as they discuss the benefits of diets low in energy density and "volumetrics."

Host: Steven Edelman, MD Guest: Philip Zeitler, MD, PhD The emergence of type 2 diabetes in both children and adolescents suggests a relationship between insulin sensitivity and puberty. What are we learning from recent studies and clinical research? Join host Dr. Steven Edelman and his guest, professor of pediatrics at the University of Colorado, Dr. Philip Zeitler as they discuss recent studies and clinical data that may shed light on this relationship.

Host: Steven Edelman, MD Guest: Candis Morello, PharmD, CDE The management of diabetes is a sophisticated multi-disciplinary approach. There are multiple benefits to both the physician treating diabetes patients and the patients themselves by increasing the role of the pharmacist to provide a collaborative approach to care and placing the patient at the center. Join host Dr. Steven Edelman and his guest, pharmacist from the Skaggs School of Pharmacy Sciences at the University of California, San Diego, Dr. Candis Morello, as they discuss the benefit of the increasing role of the pharmacist in the management of diabetes.

Host: Steven Edelman, MD Guest: Carlos Campos, MD, MPH Healthcare professionals treating Hispanic patients with diabetes need to be rigorous in monitoring and treating this disease. Special considerations are required to address adherence issues and cultural norms. How can physicians learn to care and manage this growing population? Join host Dr. Steven Edelman and his guest, executive director for the Institute for Public Health & Education Research at the University of Texas Health Sciences, Dr. Carlos Campos, as they discuss the unique opportunities in managing and treating diabetes in the Hispanic population.

Host: Steven Edelman, MD Guest: Angela Norton, RN, CDE, PHN Diabetes educators focus on helping patients living with diabetes and related conditions achieve behavior change goals and lead to better clinical outcomes and improved health status. How has the role of the certified diabetes educator changed in the management of diabetes? Join host Dr. Steven Edelman and his guest, diabetes educator at SHARP Healthcare, Angela Norton, as they discuss the benefits and increasing role of the diabetes educator in the management of diabetes.

Host: Steven Edelman, MD Guest: Francesco Rubino, MD Gastrointestinal surgery for the morbid obese has long been an option in treatment, providing positive long-lasting results such as normal blood glucose and glycosylated hemoglobin levels and the discontinuation of diabetes-related medications. Is type 2 diabetes an operable intestinal disease? Join host Dr. Steven Edelman and his guest, chief of gastrointestinal metabolic surgery at Weill Cornell Medical College, Dr. Francesco Rubino, as they discuss the implications of metabolic surgery for type 2 patients.